CPhI Worldwide Frankfurt 2025: Hall 5, Booth 50A84

Learn about FarmaImpresa Group at CPhI Worldwide Frankfurt 2025: clinical trials, private label solutions and finished products in the pharma, nutraceutical and cosmetic sectors Discover Gruppo FarmaImpresa at CPhI Worldwide Frankfurt 2025. We offer a full range of services, including clinical trials, private label solutions, and finished products in the pharma, nutraceutical, and cosmetic sectors.…

Join Us at CPHI Frankfurt 2025

We are excited to announce our participation in CPHI Frankfurt 2025, taking place from October 28 to 30! Visit us at Hall 5, Booth 50A84 to discover our latest innovations in the Pharma world! Get your free ticket now! You have until August 11 – spots are limited! What to Expect at Our Stand Explore…

CJEU Clarifies Borderline Medical Devices and Drugs

A crucial EU ruling (Case C-589/23) redefines the distinction between medical devices and medicinal products, clarifying when a substance—like D-mannose—exerts a pharmacological action under Directive 2001/83/EC The boundary between “medicinal product” and “medical device” is often subject to divergent interpretations in European markets, especially for so-called borderline products that do not clearly fall under one…

Thank You for Visiting Us at Vitafoods Europe 2025

Thank You for Visiting Our Stand The participation of Gruppo Farmaimpresa at Vitafoods Europe 2025, held from May 20 to 22 at Fira Barcelona, has successfully come to an end. This event is one of the most important international gatherings for the nutraceutical industry, and we were proud to share our latest innovations in the…

Join Us at Vitafoods Europe!

We are excited to announce our participation in Vitafoods Europe 2025 at Fira Barcelona from May 20 to 22! Visit us at Hall 3, Stand 3F188-E to discover our latest innovations in the Pharma world. What to Expect at Our Stand Explore our solutions designed to enhance product effectiveness and improve consumer health. Thanks to…

Eudamed: Introduction to Its Gradual Implementation

A New Standard for Transparency and Traceability in Medical Devices Regulation (EU) 2024/1860 has introduced significant changes to MDR (EU) 2017/745 and IVDR (EU) 2017/746, facilitating the gradual implementation of Eudamed, the European database on medical devices. This system marks a crucial step towards greater transparency, traceability, and safety in the healthcare sector. Since July…